Evaluation and management of the child with hypothyroidism

Alexander K C Leung1, Alexander A C Leung2

  • 1Department of Pediatrics, The University of Calgary, and The Alberta Children's Hospital, #200, 233 - 16th Avenue NW, Calgary, AB, T2M 0H5, Canada. aleung@ucalgary.ca.

Insights

Early diagnosis and treatment of hypothyroidism are crucial for optimal neurocognitive and physical development in children. Prompt intervention with levothyroxine, especially in infants, improves outcomes and prevents long-term complications.

Area of Science:

  • Pediatric Endocrinology
  • Developmental Neuroscience

Background:

  • Thyroid hormones are essential for normal childhood growth and neurocognitive development.
  • Timely identification and management of hypothyroidism are critical for optimizing patient outcomes.

Purpose of the Study:

  • To review the importance of prompt diagnosis and treatment of hypothyroidism in children.
  • To highlight key aspects of congenital and acquired hypothyroidism management.

Main Methods:

  • A literature search was conducted using PubMed with the keyword "hypothyroidism".

Main Results:

  • Congenital hypothyroidism stems from thyroid dysgenesis (85%) or dyshormonogenesis (15%).
  • Newborn screening detects congenital hypothyroidism, often asymptomatic in infants.
  • Hashimoto thyroiditis and iodine deficiency are leading causes of acquired hypothyroidism globally.
  • Central hypothyroidism is rare and may link to other hormonal deficiencies.

Conclusions:

  • Initiate levothyroxine treatment within the first two weeks of life for congenital hypothyroidism to enhance neurocognitive outcomes.
  • Early treatment of acquired hypothyroidism is vital for normal growth, development, and cognitive function.
  • Therapeutic goals include maintaining serum TSH < 5 mIU/L and T4 levels in the upper half of the reference range, alongside symptom resolution.
Abstract

Related Concept Videos

Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
428
Impression Management Techniques I: Managing Appearances01:29

Impression Management Techniques I: Managing Appearances

Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
216
Managing Impressions01:19

Managing Impressions

Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
169
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
630
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
535
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
286